What to check when a prescription peptide medicine arrives

Compare the delivered drug name, form, prescriber, and dispensing pharmacy with what the clinician discussed. If the product differs from a prior fill or the label is unclear, pause and call the pharmacist or prescriber. FDA flags unexpected appearance, broken packaging, missing instructions, or suspicious pharmacy information as online medication warning signs. An image on a website is not a substitute for the actual label. FDA: Concerns with unapproved GLP-1 drugs

Find the current Medication Guide or patient information for an approved product when one exists. FDA’s medicine resource explains where to locate labeling and instructions for use. Read storage and handling directions for the exact dispensed product; different formulations can have different requirements. Do not borrow directions from an online post or another patient’s box. If a shipped medicine appears to have been mishandled, ask the pharmacist before using it. FDA: Learn about your medicines

Keep the carton or label showing lot, expiration or beyond-use date, pharmacy, and manufacturer or compounder as applicable. Those details help if the pharmacy needs to investigate a defect or recall. FDA maintains a public recall portal, but absence from a recall list is not evidence that a particular package is sound. Report concerns promptly rather than trying to repair damaged packaging yourself. FDA: Recalls, market withdrawals and safety alerts

The pharmacist can explain dispensing and product instructions; the prescriber can reassess whether the treatment is appropriate and what to do about symptoms. Ask for both contacts before the first use. AHRQ encourages asking what a new medicine is for, how to use it safely, and what effects warrant attention. If you cannot obtain clear answers, resolve the uncertainty before beginning. AHRQ: Questions before taking medicine

If the package is damaged, instructions are missing, or the medicine appears warm when refrigeration is required, contact the dispensing pharmacy immediately. Do not assume it is fine because shipping took only a short time, and do not invent a storage fix. FDA’s current unapproved GLP-1 page specifically warns that inadequate refrigeration in transit can affect quality. The pharmacist can determine the correct next step for the exact product. FDA: Concerns with unapproved GLP-1 drugs

A later shipment can come from a different pharmacy, with a different device or formulation. Read every label rather than assuming the prior instructions still apply. Keep the earlier box until you have confirmed any change with the care team. If the medicine is compounded, its beyond-use date and concentration deserve particular attention from the pharmacist; a general article should not calculate or interpret an individual regimen. FDA: Compounding and the FDA Q&A